ESR1 and neoplasm: SFX-01 (SFN stabilised in alpha-cyclodextrin complex, Fig. S1a) reduced MFE in 13 of 16 patient-derived ER+ tumor samples (Fig. 1a and Supplementary Tables 1 and 2 for patient and tumor characteristics).